These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29313951)

  • 1. Systemic treatments for melasma: adjuvant therapy with a novel topical agent.
    Cohen PR
    Int J Dermatol; 2018 Mar; 57(3):e20-e21. PubMed ID: 29313951
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical tranexmic acid in the treatment of melasma.
    Bagherani N; Smoller BR
    Dermatol Ther; 2016 Nov; 29(6):389-390. PubMed ID: 26799239
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melasma: systematic review of the systemic treatments.
    Zhou LL; Baibergenova A
    Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
    Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
    Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study.
    Chung JY; Lee JH; Lee JH
    J Dermatolog Treat; 2016 Aug; 27(4):373-7. PubMed ID: 26526300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
    Pratchyapurit WO
    J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial.
    Li Y; Sun Q; He Z; Fu L; He C; Yan Y
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):393-4. PubMed ID: 23848176
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral tranexamic acid for the treatment of melasma.
    Ali FR
    Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone.
    Arreola Jauregui IE; Huerta Rivera G; Soria Orozco M; Meyer-Nava S; Paniagua Santos JE; López Zaldo JB; Meyer-Nava I; Madrid Carrillo C; Zaldo Rolón IE; Baeza Echeverría AE; Vázquez Huerta M
    J Am Acad Dermatol; 2020 Nov; 83(5):1457-1458. PubMed ID: 32151632
    [No Abstract]   [Full Text] [Related]  

  • 18. Melasma treatment with oral tranexamic acid and a novel adjuvant topical therapy.
    Cohen PR
    Cutis; 2018 Aug; 102(2):106. PubMed ID: 30235369
    [No Abstract]   [Full Text] [Related]  

  • 19. Tranexamic acid: an important adjuvant in the treatment of melasma.
    Tse TW; Hui E
    J Cosmet Dermatol; 2013 Mar; 12(1):57-66. PubMed ID: 23438143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.